Viewing Study NCT03217734


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-01-08 @ 3:43 AM
Study NCT ID: NCT03217734
Status: COMPLETED
Last Update Posted: 2019-07-09
First Post: 2017-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MAP Study: Methotrexate and Adalimumab in Psoriasis
Sponsor: Jeffrey J Crowley MD
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A16-241
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View